Moberg Financial Statements From 2010 to 2024
| MOB Stock | SEK 9.00 0.27 2.91% |
Check Moberg Pharma financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Moberg Pharma's main balance sheet or income statement drivers, such as , as well as many indicators such as . Moberg financial statements analysis is a perfect complement when working with Moberg Pharma Valuation or Volatility modules.
Moberg |
Moberg Pharma AB Company Return On Asset Analysis
Moberg Pharma's Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Current Moberg Pharma Return On Asset | -0.0249 |
Most of Moberg Pharma's fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Moberg Pharma AB is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
| Competition |
Based on the latest financial disclosure, Moberg Pharma AB has a Return On Asset of -0.0249. This is 99.72% lower than that of the Healthcare sector and significantly lower than that of the Drug Manufacturers—Specialty & Generic industry. The return on asset for all Sweden stocks is 82.21% lower than that of the firm.
Moberg Pharma AB Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Moberg Pharma's current stock value. Our valuation model uses many indicators to compare Moberg Pharma value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Moberg Pharma competition to find correlations between indicators driving Moberg Pharma's intrinsic value. More Info.Moberg Pharma AB is considered to be number one stock in return on equity category among its peers. It also is considered to be number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Moberg Pharma's earnings, one of the primary drivers of an investment's value.About Moberg Pharma Financial Statements
Moberg Pharma shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although Moberg Pharma investors may analyze each financial statement separately, they are all interrelated. The changes in Moberg Pharma's assets and liabilities, for example, are also reflected in the revenues and expenses on on Moberg Pharma's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Moberg Pharma AB , a pharmaceutical company, develops and commercializes medical products for pain and skin conditions in Europe, the United States, and internationally. Moberg Pharma AB was incorporated in 2006 and is headquartered in Bromma, Sweden. Moberg Pharma operates under Drug ManufacturersSpecialty Generic classification in Sweden and is traded on Stockholm Stock Exchange. It employs 11 people.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Moberg Stock Analysis
When running Moberg Pharma's price analysis, check to measure Moberg Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Moberg Pharma is operating at the current time. Most of Moberg Pharma's value examination focuses on studying past and present price action to predict the probability of Moberg Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Moberg Pharma's price. Additionally, you may evaluate how the addition of Moberg Pharma to your portfolios can decrease your overall portfolio volatility.